Notice of allowance for patent grant in Japan
Notice of allowance for patent grant in Japan
An important step in the continued protection of Poolbeg’s patent family
Significant progress made and well positioned for future growth
Asda has emerged as the pioneering supermarket to disclose its local fuel prices online, following indications from regulators that companies were amplifying their profit margins at the pump, a practice
Successful Artificial Intelligence led programme identifies multiple influenza drug targets
Next-Generation Oral Vaccine Programme Advancing Through Non-Dilutive Funding
Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a leading biopharmaceutical company focusing on infectious and prevalent diseases with a high unmet medical need, announces the appointment of Brendan Buckley as
Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a leading biopharmaceutical company focusing on infectious and prevalent diseases with a high unmet medical need, confirms that the Company’s
Significant milestones reached, well capitalised and positioned for future growth
POLB 001 patent portfolio strengthened through granting of US patent
Strong potential for POLB 001 to be a blockbuster treatment for severe influenza